Nektar Therapeutics (NKTR) Posts Q2 EPS Loss of $0.32, Revenues 60% Y/Y
Go back to Nektar Therapeutics (NKTR) Posts Q2 EPS Loss of $0.32, Revenues 60% Y/Y| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 65.70 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.70 | 52 Week High | $19.98 | |||
| Open | $65.70 | 52 Week Low | $10.52 | |||
| Day High | $65.70 | P/E | N/A | |||
| Day Low | $65.70 | EPS | $-1.45 | |||
| Volume | 10,936 | |||||
